# Low-dose Interleukin-2 in Women With Unexplained Miscarriages

> **NCT03970954** · PHASE1,PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 18 (actual)

## Conditions studied

- Recurrent Miscarriage

## Interventions

- **DRUG:** low-dose IL-2

## Key facts

- **NCT ID:** NCT03970954
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2023-07-28
- **Final completion:** 2024-03-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03970954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03970954, "Low-dose Interleukin-2 in Women With Unexplained Miscarriages". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03970954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*